Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Samrat Pharmachem Ltd

NSE: SAMRATPH · BSE: 530125 · Pharmaceuticals & Biotechnology · 15 announcements

Share price
₹239.05
Market cap
₹73.86 Cr
Revenue (annual)
₹289.7 Cr
Net profit (annual)
₹-3.31 Cr
P/E (TTM)
-33.5×Sector 47.4×
Promoter holding
49.09%+0.00% QoQ
FII holding
3.24%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

16:15 IST BSE
Other Announcement

Samrat Pharmachem Other Announcement

Samrat Pharmachem Limited appointed M/s Divyesh J Shah & Associates as Statutory Auditors following the expiry of the previous auditor's tenure at the 34th Annual General Meeting.

15:44 IST BSE
Other Announcement

Samrat Pharmachem Other Announcement

Samrat Pharmachem appointed Divyesh J Shah & Associates as Statutory Auditors for five years. The term spans from the 34th to 39th Annual General Meeting.

Execution
5 years
14:38 IST BSE
Other Announcement

Samrat Pharmachem Other Announcement

Samrat Pharmachem Limited submitted its Annual Secretarial Compliance Report for FY 2025-26. The report by A.A. Mulla & Associates confirms general regulatory adherence with minor historical filing delays.

14:40 IST BSE
Other Announcement

Samrat Pharmachem Other Announcement

Samrat Pharmachem Limited submitted a compliance certificate under Regulation 74(5) for the quarter ended March 31, 2026. The Registrar and Share Transfer Agent, MUFG Intime India, confirmed that securities received for dematerialisation were processed and listed on the stock exchange within prescribed timelines.